Venture Capital Firm Grove Ventures Raising $120 Million Fund
Israel-based Grove Ventures already has commitments for the majority of the amount, Dov Moran, managing partner at Grove, said in a recent interview with Calcalist
For daily updates, subscribe to our newsletter by clicking here.
In October 2017, Grove announced it closed $110 million in commitments for its first fund. Originally, Moran said, he had intended to raise a second, $110 million fund, but the amount was raised to $120 million. The fund already has commitments for the majority of the amount, Moran said.
Among Grove Ventures’ portfolio companies are Tel Aviv-based cancer detection startup Nucleai Ltd., Industry 4.0 startup 3D Signals Ltd., Israeli chip development startup NeuroBlade, and Tel Aviv-based semiconductor startup TriEye Ltd.